Laurence Doyle
Medical Oncology · Baltimore, MDNPI 1306889399
Payments from drug & device makers
$615,930in general payments, 2019–2025
Across 5 payments — averaging $123,186 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$555K
- AstraZeneca$61K
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 3 | $554,686 |
| AstraZeneca | 2 | $61,244 |
How this compares
$615,930 in reported general payments places this provider in the 65th percentile of 180 medical oncology providers in Maryland.
Other medical oncology in Baltimore
- Dung leBaltimore$18.7M
- Stephanie GaillardBaltimore$12.2M
- Ashraf BadrosBaltimore$7.2M
- Patrick BrownBaltimore$6.6M
- Nilofer AzadBaltimore$6.5M
- Jean Hoffman-CensitsBaltimore$5.7M
- Ranee MehraBaltimore$5.2M
- Michael CarducciBaltimore$4.8M
- Tanguy Lim-SeiwertBaltimore$4.6M
- Mark LevisBaltimore$4.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.